Tianyin Pharmaceutical (TPI) Q2 EPS Drops to $0.06

Tianyin Pharmaceutical (NYSE: TPI) reported Q2 EPS of $0.06, versus $0.20 reported last year. Revenue for the quarter came in at $18.2 million, versus $25.3 million reported last year.

For earnings history and earnings-related data on Tianyin Pharmaceutical (TPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
• Vireo Growth completes acquisition of C21 Investments